Shyamasundaran Kottilil (Shyam Kottilil, S Kottilil)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 29

Top Topics

Antiretroviral Therapy

Hepatitis B Virus

Prognostic Factors

Top Venues

Hepatology communications

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Maha Albukhari, Maria Bagies, Tanya Lizbeth, Shyamasundaran Kottilil
Fighting fire with fire: using infectious agents to treat persistent infection. Future microbiology 19 (13) (2024)
Maha Albukhari, Maria Bagies, Tanya Lizbeth, Shyamasundaran Kottilil
Fighting fire with fire: using infectious agents to treat persistent infection. Future microbiology (2024)
Laura Sneller, Christine Lin, Angie Price, Shyamasundaran Kottilil, Joel V Chua
RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects. Microorganisms 12 (3) (2024)
Laura Sneller, Christine Lin, Angie Price, Shyamasundaran Kottilil, Joel V Chua
RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects. Microorganisms 12 (3) (2024)
Laura Sneller, Christine Lin, Angie Price, Shyamasundaran Kottilil, Joel V Chua
RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects. Microorganisms 12 (3) (2024)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Shivakumar Narayanan, Patrick R Ching, Edward Conan Traver, Nivya George, Anthony Amoroso, Shyamasundaran Kottilil
Predictors of Nonadherence Among Patients With Infectious Complications of Substance Use Who Are Discharged on Parenteral Antimicrobial Therapy. Open forum infectious diseases 10 (1) (2022)
Arshi Khanam, Shyamasundaran Kottilil
New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter? International journal of molecular sciences 24 (1) (2022)
Arshi Khanam, Shyamasundaran Kottilil
New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter? International journal of molecular sciences 24 (1) (2022)
Arshi Khanam, Shyamasundaran Kottilil
New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter? International journal of molecular sciences 24 (1) (2022)
Shivakumar Narayanan, Patrick R Ching, Edward Conan Traver, Nivya George, Anthony Amoroso, Shyamasundaran Kottilil
Predictors of Nonadherence Among Patients With Infectious Complications of Substance Use Who Are Discharged on Parenteral Antimicrobial Therapy. Open forum infectious diseases 10 (1) (2022)
Shikha Shrivastava, Shyamasundaran Kottilil, Kenneth E Sherman, Henry Masur, Lydia Tang
CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIV/HCV-Coinfected Patients. Viruses 13 (10) (2021)
Jennifer Wellington, Andrew Ma, Shyamasundaran Kottilil, Bharath Ravichandran, Jennifer Husson, David Bruno, Eleanor Wilson
Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis. Viruses 13 (9) (2021)
Arshi Khanam, Joel V Chua, Shyamasundaran Kottilil
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. International journal of molecular sciences 22 (11) (2021)
Natarajan Ayithan, Alip Ghosh, Ankit Dwivedi, Jeffrey J Wallin, Susanna K Tan, Diana Chen, Shyamasundaran Kottilil, Bhawna Poonia
Oral Selective TLR8 Agonist Selgantolimod Induces Multiple Immune Cell Responses in Humans. Viruses 13 (12) (2021)
Arshi Khanam, Paul G Saleeb, Shyamasundaran Kottilil
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 10 (5) (2021)
Joseph T Mattingly, Julia F Slejko, Eberechukwu Onukwugha, Eleanor M Perfetto, Shyamasundaran Kottilil, C Daniel Mullins
Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis. PharmacoEconomics 38 (2) (2020)
Joseph T Mattingly, Julia F Slejko, Eleanor M Perfetto, Shyamasundaran Kottilil, C Daniel Mullins
What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism. The patient 12 (6) (2020)
Zahra R Tehrani, Saman Saadat, Ebtehal Saleh, Xin Ouyang, Niel Constantine, Anthony L DeVico, Anthony D Harris, George K Lewis, Shyamasundaran Kottilil, Mohammad M Sajadi
Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays. PloS one 15 (11) (2020)
Alip Ghosh, Rajiv K Mondal, Sara Romani, Shashwatee Bagchi, Cristiana Cairo, Charles David Pauza, Shyamasundaran Kottilil, Bhawna Poonia
Persistent gamma delta T-cell dysfunction in chronic HCV infection despite direct-acting antiviral therapy induced cure. Journal of viral hepatitis 26 (9) (2019)
Shivakumar Narayanan, Ameer Abutaleb, Kenneth E Sherman, Shyamasundaran Kottilil
Clinical features and determinants of chronicity in hepatitis E virus infection. Journal of viral hepatitis 26 (4) (2019)
Lydia Tang, M Kamat, A Shukla, M Vora, Chetan Kalal, Shyamasundaran Kottilil, S Shah
Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C. Interdisciplinary perspectives on infectious diseases 2018 (2018)
Cody Orr, Johannes Aartun, Henry Masur, Shyamasundaran Kottilil, Eric G Meissner
Characterization of changes in intrahepatic immune cell populations during HCV treatment with sofosbuvir and ribavirin. Journal of viral hepatitis 26 (3) (2018)
Ahmed M Gharib, Ma Ai Thanda Han, Eric G Meissner, David E Kleiner, Xiongce Zhao, Mary McLaughlin, Lindsay Matthews, Bisharah Rizvi, Khaled Z Abd-Elmoniem, Ralph Sinkus, Elliot Levy, Christopher Koh, Robert P Myers, G Mani Subramanian, Shyamasundaran Kottilil, Theo Heller, Joseph A Kovacs, Caryn G Morse
Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease. BioMed research international 2017 (2017)
Emily Comstock, Cheol-Woo Kim, Alison Murphy, Benjamin Emmanuel, Xi Zhang, Michael Sneller, Bhawna Poonia, Shyamasundaran Kottilil
Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis. PloS one 12 (12) (2017)